Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Acquisitions (2023)

Perspective Therapeutics' Acquisitions history spans 1 years, with the latest figure at $2.7 million for Q1 2023.

  • For Q1 2023, Acquisitions changed N/A year-over-year to $2.7 million; the TTM value through Dec 2023 reached $2.7 million, changed N/A, while the annual FY2023 figure was $2.7 million, N/A changed from the prior year.
  • Acquisitions for Q1 2023 was $2.7 million at Perspective Therapeutics.
  • Across five years, Acquisitions topped out at $2.7 million in Q1 2023 and bottomed at $2.7 million in Q1 2023.